Support for Study into Impact of Semaglutide in Amyloid Positivity (ISAP)

We are pleased to be supporting this study into the effects of oral semaglutide on the build-up of proteins in the brain characterising Alzheimer’s Disease and other cognitive impairments. Invitations to join this research study are being posted to relevant members of the Airwave cohort. 

The study is being conducted by researchers at University of Oxford, led by Dr Ivan Koychev. Attached to this page are the covering letter of invitation and the study's Participant Information Sheet (PIS). The study also has its own website here.

Andy Heard
Database Manager